Related Experiment Videos
Status epilepticus controlled by althesin infusion.
Anaesthesia and Intensive Care
|February 1, 1979
Summary
Althesin effectively controls refractory status epilepticus. Its rapid metabolism prevents drug accumulation, offering a significant advantage over other treatments for this neurological emergency.
Area of Science:
- Anesthesiology
- Neurology
- Pharmacology
Background:
- Status epilepticus (SE) is a neurological emergency requiring prompt and effective treatment.
- Refractory SE often necessitates the use of agents with favorable pharmacokinetic profiles.
Observation:
- Althesin, an anesthetic agent, was administered to three patients with refractory status epilepticus.
- Clinical response and adverse events were monitored.
Findings:
- Althesin successfully controlled status epilepticus in all three patients, even when other agents had failed.
- The drug's rapid metabolism prevents accumulation, distinguishing it from other anesthetic agents used for SE.
Implications:
- Althesin presents a viable therapeutic option for managing difficult-to-treat status epilepticus.
- Its pharmacokinetic profile may reduce the risk of prolonged sedation or other adverse effects associated with drug buildup.